- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01514318
Encore Revelation Hip Stem
October 31, 2012 updated by: Encore Medical, L.P.
A Long-term Follow Up Study of the Revelation™ Hip Stem
The purpose of this study is to obtain long-term (10+ yrs) clinical and patient outcomes data on patients who received the Revelation Hip Stem prior to 2002.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
8
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Austin, Texas, United States, 78746
- Westlake Orthopaedics Spine & Sports
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The study will include only subjects who received the Revelation Hip Stem prior to 2002 and who voluntarily consent to take part in this study.
Description
Inclusion Criteria:
- Subjects must have received the Revelation™ Hip Stem as part of a total hip arthroplasty prior to 2002.
- Surgery must have been a primary total hip replacement
- Subject must have received only one primary hip replacement per hospitalization
- Subject must have had a diagnosis of inflammatory tissue disorder, osteoarthritis, post-traumatic arthritis/secondary arthritis or avascular necrosis
- Subject must be willing and able to sign the informed consent document
Exclusion Criteria:
- Subject must not have had any previous hip implants (hemi or total joint)
- Subject has a mental condition that may interfere with the ability to give an informed consent (i.e., severe mental retardation such that the subject cannot understand the informed consent process, global dementia, prior strokes that interfere with the subject's cognitive abilities, senile dementia, and Alzheimer's Disease)
- Subject is a prisoner
- Subject is pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Revelation
Subjects who received the Revelation Hip Stem prior to 2002 and have agreed to come into the office for a single visit.
|
Subjects who received the Revelation Hip Stem prior to 2002 and still maintain the original device.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Survivorship of the Device
Time Frame: 10 year
|
The subject meets the inclusion/exclusion criteria of the study and received a Revelation Hip Stem prior to 2002 that has survived intact without any type of surgery to revise or remove parts or the whole prosthesis.
|
10 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Western Ontario McMaster Arthritis Index (WOMAC)
Time Frame: 10 year
|
Standardized questionnaire used by health professionals to evaluate the condition of patients with osteoarthritis of the knee and hip.
It assesses the pain, joint stiffness, physical, social & emotional function of a person with osteoarthritis in determining the overall level of disability.
The WOMAC measures five items for pain (score range 0-20), two for stiffness (score range 0-8), and 17 for functional limitation (score range 0-68).
For each item, the possible range of scores is therefore 0-100.
Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.
Physical functioning questions cover everyday activities such as stair use, standing up from a sitting or lying position, standing, bending, walking, getting in and out of a car, shopping, putting on or taking off socks, lying in bed, getting in or out of a bath, sitting, and heavy and light household duties.
|
10 year
|
|
Harris Hip Score
Time Frame: 10 year
|
A tool for the evaluation of how a patient is doing after their hip is replaced.
Based on a total of 100 points possible, each question is awarded a certain number of points based on how it is answered.
Questions are further grouped into four categories.
The first category is pain, the second category is function, third is functional activities and finally the physical exam results are tabulated, and based on your range of motion.
The score is reported as 90-100 for excellent results, 80-90 being good, 70-79 fair, 60-69 poor, and below 60 a failed result.
|
10 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Frosty Moore, M.D., Westlake Orthopaedics Spine & Sports
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2012
Primary Completion (Actual)
July 1, 2012
Study Completion (Actual)
July 1, 2012
Study Registration Dates
First Submitted
December 22, 2011
First Submitted That Met QC Criteria
January 20, 2012
First Posted (Estimate)
January 23, 2012
Study Record Updates
Last Update Posted (Estimate)
November 30, 2012
Last Update Submitted That Met QC Criteria
October 31, 2012
Last Verified
October 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PS-805
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis, Hip
-
Poznan University of Medical SciencesRecruitingHip Pain Chronic | Hip Osteoarthritis | Hip ArthropathyPoland
-
University of MiamiNot yet recruiting
-
Poznan University of Medical SciencesRecruiting
-
Tulip MedicineCompletedRehabilitation | Hip Osteoarthritis | Hip Arthroplasty Replacement | Hip Arthroplasty, TotalKazakhstan
-
Poznan University of Medical SciencesNot yet recruitingHip Osteoarthritis | Arthropathy of HipPoland
-
Poznan University of Medical SciencesRecruitingHip Pain Chronic | Hip OsteoarthritisPoland
-
Poznan University of Medical SciencesNot yet recruitingHip Osteoarthritis | Arthropathy of HipPoland
-
Istituto Ortopedico RizzoliCompleted
-
Poznan University of Medical SciencesNot yet recruitingHip Osteoarthritis
-
Artvin Coruh UniversityCompletedHip OsteoarthritisTurkey (Türkiye)
Clinical Trials on Revelation Hip Stem (Revelation)
-
DePuy OrthopaedicsTerminatedOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis | Acute FractureUnited States
-
Canadian Radiostereometric Analysis NetworkCompleted
-
Association pour le Développement et l'Enseignement...RecruitingOsteoarthritis, HipFrance
-
Zimmer BiometBiomet Spain Orthopaedics S.L.Terminated
-
Istituto Ortopedico RizzoliCompleted
-
Stryker Australia Pty Ltd.RecruitingArthritis (E.G., Degenerative Joint Disease (DJD), Osteoarthritis, and Rheumatoid Arthritis (RA))Australia
-
Smith & Nephew Orthopaedics AGCompleted
-
Biomet Orthopedics, LLCTerminatedOsteoarthritis, Hip | Traumatic Arthritis of HipUnited States
-
Ain Shams UniversityCompletedLength of the Femoral Stem in Arthroplasty Done for Patients With Proximal Femoral Metastatic LesionArthroplasty | Metastatic Bone Tumor | Pathological FractureEgypt
-
Zimmer BiometCompletedOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Prosthesis FailureSwitzerland, Germany, Italy, United Kingdom